These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23874832)

  • 1. Differential impact of two risk communications on antipsychotic prescribing to people with dementia in Scotland: segmented regression time series analysis 2001-2011.
    Guthrie B; Clark SA; Reynish EL; McCowan C; Morales DR
    PLoS One; 2013; 8(7):e68976. PubMed ID: 23874832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of direct healthcare professional communication on prescribing practice in the UK hospital setting: an interrupted time series analysis.
    Thomas SK; Hodson J; McIlroy G; Dhami A; Coleman JJ
    Drug Saf; 2013 Jul; 36(7):557-64. PubMed ID: 23657825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotic Prescribing to Patients Diagnosed with Dementia Without a Diagnosis of Psychosis in the Context of National Guidance and Drug Safety Warnings: Longitudinal Study in UK General Practice.
    Stocks SJ; Kontopantelis E; Webb RT; Avery AJ; Burns A; Ashcroft DM
    Drug Saf; 2017 Aug; 40(8):679-692. PubMed ID: 28439716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the Centers for Medicare & Medicaid Services' National Partnership to Improve Dementia Care With the Use of Antipsychotics and Other Psychotropics in Long-term Care in the United States From 2009 to 2014.
    Maust DT; Kim HM; Chiang C; Kales HC
    JAMA Intern Med; 2018 May; 178(5):640-647. PubMed ID: 29550856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotics in dementia: prevalence and quality of antipsychotic drug prescribing in UK mental health services.
    Barnes TR; Banerjee S; Collins N; Treloar A; McIntyre SM; Paton C
    Br J Psychiatry; 2012 Sep; 201(3):221-6. PubMed ID: 22790679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a complex intervention to improve primary care prescribing: a phase IV segmented regression interrupted time series analysis.
    MacBride-Stewart S; Marwick C; Houston N; Watt I; Patton A; Guthrie B
    Br J Gen Pract; 2017 May; 67(658):e352-e360. PubMed ID: 28347986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotic prescribing in care homes before and after launch of a national dementia strategy: an observational study in English institutions over a 4-year period.
    Szczepura A; Wild D; Khan AJ; Owen DW; Palmer T; Muhammad T; Clark MD; Bowman C
    BMJ Open; 2016 Sep; 6(9):e009882. PubMed ID: 27650756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observational cohort study: deprivation and access to anti-dementia drugs in the UK.
    Cooper C; Lodwick R; Walters K; Raine R; Manthorpe J; Iliffe S; Petersen I
    Age Ageing; 2016 Jan; 45(1):148-54. PubMed ID: 26582758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic drug prescribing and mortality in people with dementia before and during the COVID-19 pandemic: a retrospective cohort study in Wales, UK.
    Schnier C; McCarthy A; Morales DR; Akbari A; Sofat R; Dale C; Takhar R; Mamas MA; Khunti K; Zaccardi F; Sudlow CL; Wilkinson T;
    Lancet Healthy Longev; 2023 Aug; 4(8):e421-e430. PubMed ID: 37543047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic prescribing in nursing homes: an audit report.
    Morrison A
    Qual Prim Care; 2009; 17(5):359-62. PubMed ID: 20003722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of legislative changes on patterns of antipsychotic prescribing and self-poisoning in Scotland: 2000-06.
    Poon H; Elliot V; Bateman DN; Waring WS
    J Toxicol Sci; 2007 Feb; 32(1):1-7. PubMed ID: 17327689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends and factors associated with antipsychotic use among elderly patients with dementia in Taiwan from 2005 to 2013: a population-based study.
    Chiu YW; Huang CW; Chen PJ; Yu NW; Tsai HJ; Wu CS; Chang CM
    Int Clin Psychopharmacol; 2017 Sep; 32(5):262-270. PubMed ID: 28542035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of a Communication Training Program With Use of Antipsychotics in Nursing Homes.
    Tjia J; Hunnicutt JN; Herndon L; Blanks CR; Lapane KL; Wehry S
    JAMA Intern Med; 2017 Jun; 177(6):846-853. PubMed ID: 28418449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged use of antipsychotic medications in long-term aged care in Australia: a snapshot from the HALT project.
    Harrison F; Cations M; Jessop T; Aerts L; Chenoweth L; Shell A; Sachdev P; Hilmer S; Draper B; Brodaty H
    Int Psychogeriatr; 2020 Mar; 32(3):335-345. PubMed ID: 31969207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic prescribing for Alzheimer's disease and related disorders in specialized settings from 2010 to 2014 in France: a repeated cross-sectional study.
    Tifratene K; Manera V; Fabre R; Gros A; Thummler S; Pradier C; Robert P; David R
    Alzheimers Res Ther; 2017 Apr; 9(1):34. PubMed ID: 28446209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rates of Antipsychotic Drug Prescribing Among People Living With Dementia During the COVID-19 Pandemic.
    Luo H; Lau WCY; Chai Y; Torre CO; Howard R; Liu KY; Lin X; Yin C; Fortin S; Kern DM; Lee DY; Park RW; Jang JW; Chui CSL; Li J; Reich C; Man KKC; Wong ICK
    JAMA Psychiatry; 2023 Mar; 80(3):211-219. PubMed ID: 36696128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second-generation antipsychotic drug use in hospital inpatients with dementia: the impact of a safety warning on rates of prescribing.
    McIlroy G; Thomas SK; Coleman JJ
    J Public Health (Oxf); 2015 Jun; 37(2):346-52. PubMed ID: 24681910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotic prescribing patterns in a Medicare Advantage population of older individuals with dementia.
    Kester R; Unützer J; Hogan D; Huang H
    J Ment Health; 2017 Apr; 26(2):167-171. PubMed ID: 27841049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvements in the prescribing of antipsychotics in dementia and psychogeriatric units in New Zealand.
    Tordoff JM; Ailabouni NJ; Browne DP; Al-Sallami HS; Gray AR
    Int J Clin Pharm; 2016 Aug; 38(4):941-9. PubMed ID: 27241343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in diagnosis and treatment for people with dementia in the UK from 2005 to 2015: a longitudinal retrospective cohort study.
    Donegan K; Fox N; Black N; Livingston G; Banerjee S; Burns A
    Lancet Public Health; 2017 Mar; 2(3):e149-e156. PubMed ID: 29253388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.